TCTR20220607003已完成1 期
Effects of Botulinum Toxin Type A Injection with Microneedle in Patients with Hemifacial Spasm
Ratchadapisek Somphot Fund0 个研究点目标入组 62 人开始时间: 2022年6月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 90 Years（—）
- 性别
- All
入选标准
- •primary hemifacial spasm
排除标准
- •pregnancy, myasthenia gravis, allergy to botulinum toxin
研究者
相似试验
尚未招募
不适用
Influence of Botulinum Toxin A injections into the calf muscles on the recurvation of the knee joint in patients with spastic infantile cerebral palsyG80.0Q66.0Spastic quadriplegic cerebral palsyTalipes equinovarusDRKS00022883niversitätsklinik HeidelbergKlinik für Orthopädie und Unfallchirurgie20
进行中（未招募）
不适用
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.EUCTR2009-018226-29-NL26
已完成
3 期
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166NL-OMON39359Revalidatiecentrum Het Roessingh26
已完成
2 期
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42IRCT20190129042540N1Rafsanjan University of Medical Sciences50
进行中（未招募）
不适用
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the regular therapy program will be compared to each other.Study population: children with CP, spastic hemiparesis, aged 2.5 – 12 years.EUCTR2006-002175-40-NL60